Table 2.
Comparison of apoptosis of MGCs, CCs and FF hormones between NOR and DOR group
| Parameters | NOR (n = 118) | DOR (n = 46) | P value |
|---|---|---|---|
| MGCs necrosis rate (%) | 3.66 (0.70, 9.94) | 5.15 (1.19, 13.52) | ns |
| MGCs early apoptosis rate (%) | 0.49 (0.22–2.32) | 1.26 (0.48–1.80) | < 0.0001 |
| MGCs late apoptosis rate (%) | 1.96 (0.28–5.59) | 4.88 (2.02–9.98) | < 0.001 |
| MGCs total apoptosis rate (%) | 2.67 (0.87–6.63) | 5.55 (3.80–11.39) | < 0.0001 |
| CCs necrosis rate (%) | 1.14 (0.084–1.86) | 1.07 (0.44–2.10) | ns |
| CCs early apoptosis rate (%) | 0.23 (0.045–0.72) | 0.29 (0.20–0.60) | ns |
| CCs late apoptosis rate (%) | 4.27 (0.72–13.40) | 6.63 (2.69–11.80) | ns |
| CCs total apoptosis rate (%) | 5.60 (1.44–14.42) | 6.98 (3.12–11.99) | ns |
| FF AMH (ng/mL) | 3.48 (2.06–5.84) | 1.42 (0.98–2.43) | < 0.0001 |
| FF E2 (pmol/L) | 628,100 (478,044–872,500) | 893,500 (614,310–1,085,000) | < 0.05 |
| FF P (ng/mL) | 18,900 (12,945–45,380) | 13,800 (10,350–16,950) | < 0.05 |
| FF T (nmol/L) | 5.30 (4.00–8.40) | 5.99 (4.26–8.34) | ns |
All parameters were shown as median (interquartile range (IQR)). P < 0.05 (two-sided) was considered statistically significant, Mann-Whitney U test was used